RPT193

· RAPT Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RPT193, covering 2026-02-25 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma [Phase 2]